In January 2025, Ashva Wearable Technologies, a Ghaziabad-based startup, captivated audiences on Shark Tank India Season 4 with its AI-powered device, Fitknees. Founded by Anmol Ajay Saxena, Ashva secured ₹50 lakh for 4% equity, spotlighting its mission to transform knee health diagnostics. With India facing a growing knee health crisis, Ashva’s innovative wearable technology is making waves in healthcare. This article explores the company’s journey, its founder’s vision, and its impact on medical technology.
Shark Tank India Breakthrough
On January 27, 2025, Anmol Saxena pitched Fitknees on Shark Tank India, seeking ₹50 lakh for 1.25% equity, valuing Ashva at ₹40 crore. The AI-driven wearable, which diagnoses knee health in 10 minutes, impressed the Sharks with its live demo. After negotiations, Namita Thapar and Anupam Mittal offered ₹50 lakh for 4% equity, a deal Saxena accepted, as reported by The Times of India.
Post-airing, Ashva saw a 30% spike in inquiries from hospitals, per Startup Article. The deal highlighted Fitknees’ potential to address India’s knee health challenges.
Why It Matters: The Shark Tank success validates the need for accessible, non-invasive diagnostic tools, signaling a shift toward wearable health tech in India.
Founder Profile: Anmol Ajay Saxena
Anmol Saxena, a 29-year-old engineer from Ghaziabad, founded Ashva in 2021. Inspired by her own knee pain during a college weight-loss journey and her mother’s eight-year struggle with chronic knee issues, Saxena envisioned a solution to simplify knee diagnostics. After working 2.5 years at Ford Motors, she quit to consult 75 physiotherapists and observe 30 surgeries, ensuring Fitknees met real-world needs.
“I wanted to create a solution that would empower people to take control of their knee health,” Saxena told The Times of India in 2025. Her persistence earned her a spot on Forbes India’s 2025 “30 Under 30” list.
Why It Matters: Saxena’s journey highlights how personal challenges can drive innovation, inspiring entrepreneurs to tackle underserved healthcare issues.
Funding and Growth Trajectory
Ashva has been largely bootstrapped, with Saxena and angel investors funding initial development. The Shark Tank deal of ₹50 lakh in January 2025 bolstered its expansion plans. In October–November 2024, Ashva achieved profitability, generating ₹17.5 lakh in sales, per Startup Article. The company is now eyeing a Series A round to scale production and enter international markets.
| Funding Source | Amount | Date | Key Investors |
|---|---|---|---|
| Bootstrapped/Angel | Undisclosed | 2021–2024 | Anmol Saxena, Angels |
| Shark Tank Deal | ₹50 lakh | January 2025 | Namita Thapar, Anupam Mittal |
Why It Matters: Ashva’s funding success reflects growing investor confidence in health tech, paving the way for startups addressing chronic conditions.
Net Worth and Market Impact
Ashva’s valuation stood at ₹12.5 crore post-Shark Tank, based on the 4% equity deal. Saxena’s personal net worth is not publicly disclosed but is tied to her stake in the company. Fitknees and its companion device, Fitmust, are used in over 115 orthopedic hospitals, including Apollo and Manipal, per Startup Article. With 6 crore Indians diagnosed with osteoarthritis annually, Ashva addresses a critical need, as noted in a 2024 Indian Journal of Orthopaedics study.
Why It Matters: Ashva’s growth underscores the potential of wearable tech to reduce healthcare costs and improve outcomes for millions.
Case Study: Fitknees in Action
Fitknees, priced at ₹7.5 lakh for the combo with Fitmust, offers real-time knee diagnostics via AI, producing a “KneePort” report for patients and doctors. A 2024 trial at Aster Hospitals showed a 20% reduction in diagnostic time for knee injuries, enhancing patient throughput. The standalone Fitmust device, at ₹85,000, targets physiotherapy centers, broadening accessibility.
Why It Matters: Fitknees’ adoption by top hospitals demonstrates its potential to streamline diagnostics, setting a precedent for AI-driven healthcare solutions.
Challenges and Future Plans
Ashva faces challenges, including the premium pricing of Fitknees, which may limit adoption in smaller clinics. Competition from global health tech firms also looms. However, Saxena plans to lower costs through economies of scale and expand to Southeast Asia by 2026. Partnerships with insurance providers are in the works to enhance affordability.
Why It Matters: Overcoming pricing barriers will determine Ashva’s ability to democratize knee care, offering lessons for health tech scalability.
Conclusion
Ashva’s Fitknees has redefined knee health diagnostics, blending AI innovation with a compelling founder story. Anmol Saxena’s Shark Tank India success and strategic funding have positioned Ashva as a leader in wearable health tech. As India grapples with rising knee health issues, Ashva’s growth signals a broader shift toward accessible, tech-driven healthcare. With global ambitions, the startup is poised to inspire entrepreneurs and improve lives, proving that personal struggles can fuel transformative solutions.
FAQ
What is Fitknees by Ashva?
Fitknees is an AI-powered wearable device by Ashva that diagnoses knee health in 10 minutes, paired with Fitmust for comprehensive analysis.
Who founded Ashva?
Anmol Ajay Saxena, an engineer from Ghaziabad, founded Ashva in 2021.
What was Ashva’s Shark Tank deal?
In January 2025, Namita Thapar and Anupam Mittal invested ₹50 lakh for 4% equity.
What is Ashva’s valuation?
Ashva was valued at ₹12.5 crore post-Shark Tank, based on the equity deal.
What are Ashva’s future plans?
Ashva aims to reduce costs, expand to Southeast Asia by 2026, and partner with insurance providers.
Check out more on Startup News and Startup Funding News. Stay connected with us across all our social media platforms: Facebook, Instagram, LinkedIn, X (formerly Twitter), and Join Our Community.
About The Author
